ID: ALA119555

Max Phase: Preclinical

Molecular Formula: C16H18N2O2

Molecular Weight: 270.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN1Cc2c(N)cccc2C(c2ccc(O)c(O)c2)C1

Standard InChI:  InChI=1S/C16H18N2O2/c1-18-8-12(10-5-6-15(19)16(20)7-10)11-3-2-4-14(17)13(11)9-18/h2-7,12,19-20H,8-9,17H2,1H3

Standard InChI Key:  ODIYTWXTFQEXKZ-UHFFFAOYSA-N

Associated Targets(non-human)

cyclic AMP phosphoprotein 35 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Dopamine D2 receptor 7893 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 270.33Molecular Weight (Monoisotopic): 270.1368AlogP: 2.26#Rotatable Bonds: 1
Polar Surface Area: 69.72Molecular Species: NEUTRALHBA: 4HBD: 3
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.39CX Basic pKa: 8.26CX LogP: 1.77CX LogD: 1.06
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.55Np Likeness Score: 0.75

References

1. Dandridge PA, Kaiser C, Brenner M, Gaitanopoulos D, Davis LD, Webb RL, Foley JJ, Sarau HM..  (1984)  Synthesis, resolution, absolute stereochemistry, and enantioselectivity of 3',4'-dihydroxynomifensine.,  27  (1): [PMID:6317860] [10.1021/jm00367a006]

Source